Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001787792-22-000001
Filing Date
2022-07-26
Accepted
2022-07-26 12:36:42
Documents
1
Effectiveness Date
2022-07-26
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6454
  Complete submission text file 0001787792-22-000001.txt   7578
Mailing Address 630 FLUSHING AVENUE, SUITE #104 BROOKLYN NY 11206
Business Address 515 MADISON AVENUE NEW YORK NY 10022 917-930-4332
Fisher Wallace Laboratories, Inc. (Filer) CIK: 0001787792 (see all company filings)

EIN.: 208131183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-453724 | Film No.: 221105914
SIC: 3841 Surgical & Medical Instruments & Apparatus